Kein Seong Mun
- Cancer Research top 10%
-
- PI3K/AKT/mTOR signaling in cancer 2
-
- HER2/EGFR in Cancer Research 2
-
- Glioma Diagnosis and Treatment 4
-
- Neuroblastoma Research and Treatments 3
-
- Renal cell carcinoma treatment 2
- Lung Cancer Treatments and Mutations 2
-
- Histiocytic Disorders and Treatments 2
-
- Head and Neck Surgical Oncology 2
- Co-authors
- Norhafiza Mohd ArshadNoor Hasima NagoorKhalijah AwangShaik NyamathullaMark H. GreeneRuihong WangShyam K. SharanChu‐Xia Deng
- Journals
- Nature Medicine (1 paper)SHILAP Revista de lepidopterología (2 papers)Toxicology and Applied Pharmacology (1 paper)
- Partner nations
- MalaysiaUnited StatesAustralia
In The Last Decade
Kein Seong Mun
23 papers receiving 414 citations
Peers
Comparison fields: 5 of 69
- Cancer Research 162
- Pharmacology 30
- Molecular Biology 214
- Oncology 74
- Molecular Medicine 12
Countries citing papers authored by Kein Seong Mun
This map shows the geographic impact of Kein Seong Mun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kein Seong Mun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kein Seong Mun more than expected).
Fields of papers citing papers by Kein Seong Mun
This network shows the impact of papers produced by Kein Seong Mun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kein Seong Mun. The network helps show where Kein Seong Mun may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kein Seong Mun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2022 | 76 | |
| 4 | 2021 | 8 | |
| 5 | 2021 | 6 | |
| 6 | 2020 | 6 | |
| 7 | 2020 | 8 | |
| 8 | 2019 | 4 | |
| 9 | 2019 | 9 | |
| 10 | 2019 | 8 | |
| 11 | 2019 | 0 | |
| 12 | 2019 | 10 | |
| 13 | 2018 | 15 | |
| 14 | 2017 | 4 | |
| 15 | 2017 | 1 | |
| 16 | 2015 | 9 | |
| 17 | 2013 | 9 | |
| 18 | 2012 | 26 | |
| 19 | 2011 | 177 | |
| 20 | 2005 | 19 |
About Kein Seong Mun
Kein Seong Mun is a scholar working on Aging, Pharmacology and Genetics, having authored 26 papers that have together received 419 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (4 papers), Neuroblastoma Research and Treatments (3 papers), Renal cell carcinoma treatment (2 papers), Histiocytic Disorders and Treatments (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), HER2/EGFR in Cancer Research (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Head and Neck Surgical Oncology (2 papers). The work is most often cited by research in Cancer Research (162 citations), Pharmacology (30 citations) and Molecular Biology (214 citations). Kein Seong Mun has collaborated with scholars based in Malaysia, United States and Australia. Frequent co-authors include Norhafiza Mohd Arshad, Noor Hasima Nagoor, Khalijah Awang, Shaik Nyamathulla, Mark H. Greene, Ruihong Wang, Shyam K. Sharan, Chu‐Xia Deng, Stephen W. Byers and Luca Cavallone. Their work appears in journals such as Nature Medicine, SHILAP Revista de lepidopterología and Toxicology and Applied Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.